{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:17:12Z","timestamp":1793593032183,"version":"4.5.0"},"reference-count":122,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7,31]]},"DOI":"10.1097\/qad.0b013e3283536ba8","type":"journal-article","created":{"date-parts":[[2012,3,31]],"date-time":"2012-03-31T10:33:10Z","timestamp":1333189990000},"page":"1457-1472","source":"Crossref","is-referenced-by-count":141,"title":["Candida and candidiasis in HIV-infected patients"],"prefix":"10.1097","volume":"26","author":[{"given":"Antonio","family":"Cassone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cauda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210130","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJM198408093110602","article-title":"Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome.","volume":"311","author":"Klein","year":"1984","journal-title":"N Engl J Med"},{"key":"R2-2-20210130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.7326\/0003-4819-104-1-54","article-title":"Oral candidiasis as a marker for esophageal candidiasis in the acquired immunodeficiency syndrome.","volume":"104","author":"Tavitian","year":"1986","journal-title":"Ann Intern Med"},{"key":"R3-2-20210130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.it.2010.12.002","article-title":"Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus.","volume":"32","author":"Guihot","year":"2011","journal-title":"Trends Immunol"},{"key":"R4-2-20210130","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1182\/blood-2011-01-331306","article-title":"HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.","volume":"117","author":"Sauce","year":"2011","journal-title":"Blood"},{"key":"R5-2-20210130","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00042560-199712150-00002","article-title":"Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents.","volume":"16","author":"Pakker","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R6-2-20210130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R7-2-20210130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.280.1.72","article-title":"Recovery of the immune system with antiretroviral therapy. The end of opportunism.","volume":"280","author":"Powderly","year":"1998","journal-title":"JAMA"},{"key":"R8-2-20210130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9343(94)90300-X","article-title":"Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance.","volume":"97","author":"Sangeorzan","year":"1994","journal-title":"Am J Med"},{"key":"R9-2-20210130","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.humpath.2010.06.007","article-title":"Opportunistic disorders of the gastrointestinal tract in the age of highly active antiretroviral therapy.","volume":"41","author":"Huppmann","year":"2010","journal-title":"Hum Pathol"},{"key":"R10-2-20210130","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2165\/00003495-200363100-00004","article-title":"Invasive oesophageal candidiasis.","volume":"63","author":"Vazquez","year":"2003","journal-title":"Drugs"},{"key":"R13-2-20210130","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/514571","article-title":"Refractory mucosal candidiasis in patients with human immunodeficiency virus infection.","volume":"26","author":"Fichtenbaum","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R14-2-20210130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1468-1293.2009.00807.x","article-title":"Upper gastrointestinal endoscopic findings in the era of highly active antiretroviral therapy.","volume":"11","author":"Nkuize","year":"2010","journal-title":"HIV Med"},{"key":"R15-2-20210130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1086\/375746","article-title":"HIV Epidemiology Research Study (HERS) GroupLongitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.","volume":"188","author":"Ohmit","year":"2003","journal-title":"J Infect Dis"},{"key":"R16-2-20210130","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/infdis\/174.4.821","article-title":"Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients.","volume":"174","author":"Revankar","year":"1996","journal-title":"J Infect Dis"},{"key":"R17-2-20210130","first-page":"2511","article-title":"Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients.","volume":"12","author":"Revankar","year":"1998","journal-title":"AIDS"},{"key":"R18-2-20210130","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1086\/513950","article-title":"Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients.","volume":"26","author":"Revankar","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R19-2-20210130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0002-9343(98)00137-5","article-title":"A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance.","volume":"105","author":"Revankar","year":"1998","journal-title":"Am J Med"},{"key":"R20-2-20210130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/0022034511399284","article-title":"Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis.","volume":"23","author":"Fidel","year":"2011","journal-title":"Adv Dent Res"},{"key":"R21-2-20210130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/154407370601900107","article-title":"The effects of HIV infection on oral mucosal immunity.","volume":"19","author":"Challacombe","year":"2006","journal-title":"Adv Dent Res"},{"key":"R22-2-20210130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/714031126","article-title":"Distinct protective host defenses against oral and vaginal candidiasis.","volume":"40","author":"Fidel","year":"2002","journal-title":"Med Mycol"},{"key":"R23-2-20210130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.idc.2006.07.004","article-title":"Invasive candidiasis.","volume":"20","author":"Pappas","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"R24-2-20210130","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R25-2-20210130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9378(98)80001-X","article-title":"Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations.","volume":"178","author":"Sobel","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"R26-2-20210130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/cid\/cir802","article-title":"Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection.","volume":"54","author":"Achenbach","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R27-2-20210130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.","volume":"332","author":"Puel","year":"2011","journal-title":"Science"},{"key":"R28-2-20210130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1521-4028(200206)42:3<207::AID-JOBM207>3.0.CO;2-C","article-title":"Candida dubliniensis, a new fungal pathogen.","volume":"42","author":"Gutierrez","year":"2002","journal-title":"J Basic Microbiol"},{"key":"R30-2-20210130","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/MMBR.00009-06","article-title":"Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans.","volume":"71","author":"Biswas","year":"2007","journal-title":"Microbiol Mol Biol Rev"},{"key":"R31-2-20210130","first-page":"1034","article-title":"The quorum sensing molecule farnesolhomoserine lactone and dodecanol operate via distinct modes of action in Candida albicans eukaryot.","volume":"10","author":"Hall","year":"2011","journal-title":"Cell"},{"key":"R32-2-20210130","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1567-1364.2009.00562.x","article-title":"Why does Candida albicans switch.","volume":"9","author":"Soll","year":"2009","journal-title":"FEMS Yeast Res"},{"key":"R33-2-20210130","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.1128\/MCB.23.22.8189-8201.2003","article-title":"Identification and characterization of a Candida albicans mating pheromone.","volume":"23","author":"Bennett","year":"2003","journal-title":"Mol Cell Biol"},{"key":"R36-2-20210130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nri2939","article-title":"Immunity to fungal infections.","volume":"11","author":"Romani","year":"201","journal-title":"Nat Rev Immunol"},{"key":"R38-2-20210130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1462-5822.2009.01412.x","article-title":"Interactions of Candida albicans with epithelial cells.","volume":"12","author":"Zhu","year":"2010","journal-title":"Cell Microbiol"},{"key":"R39-2-20210130","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1177\/0022034510368784","article-title":"Epithelial cells and innate antifungal defense.","volume":"89","author":"Weindl","year":"2010","journal-title":"J Dent Res"},{"key":"R40-2-20210130","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.micinf.2011.06.009","article-title":"Candida albicans interactions with epithelial cells and mucosal immunity.","volume":"13","author":"Naglik","year":"2011","journal-title":"Microbes Infect"},{"key":"R41-2-20210130","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.mib.2011.06.001","article-title":"Mucosal biofilms of Candida albicans.","volume":"14","author":"Ganguly","year":"2011","journal-title":"Curr Opin Microbiol"},{"key":"R42-2-20210130","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/MMBR.67.3.400-428.2003","article-title":"Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.","volume":"67","author":"Naglik","year":"2003","journal-title":"Microbiol Mol Biol Rev"},{"key":"R43-2-20210130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/mmy.39.4.303.313","article-title":"Aspartyl proteinases of Candida albicans and their role in pathogenicity.","volume":"39","author":"De Bernardis","year":"2001","journal-title":"Med Mycol"},{"key":"R44-2-20210130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1515\/BC.2002.117","article-title":"Secreted aspartic proteases as virulence factors of Candida species.","volume":"383","author":"Monod","year":"2002","journal-title":"Biol Chem"},{"key":"R45-2-20210130","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1128\/IAI.00248-10","article-title":"Limited role of secreted aspartyl proteinases Sap1 to Sap6 in Candida albicans virulence and host immune response in murine hematogenously disseminated candidiasis.","volume":"78","author":"Correia","year":"2010","journal-title":"Infect Immun"},{"key":"R46-2-20210130","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1099\/mic.0.2008\/022293-0","article-title":"Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis.","volume":"154","author":"Naglik","year":"2008","journal-title":"Microbiology"},{"key":"R47-2-20210130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1086\/376536","article-title":"Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections.","volume":"188","author":"Naglik","year":"2003","journal-title":"J Infect Dis"},{"key":"R48-2-20210130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.trsl.2006.11.006","article-title":"Cleavage of E-cadherin: a mechanism for disruption of the intestinal epithelial barrier by Candida albicans.","volume":"149","author":"Frank","year":"2007","journal-title":"Transl Res"},{"key":"R49-2-20210130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1601-0825.2011.01856.x","article-title":"CD8 T cells and E-cadherin in host responses against oropharyngeal candidiasis.","volume":"18","author":"Quimby","year":"2012","journal-title":"Oral Dis"},{"key":"R50-2-20210130","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/IAI.00054-07","article-title":"Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p.","volume":"75","author":"Villar","year":"2007","journal-title":"Infect Immun"},{"key":"R51-2-20210130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.molimm.2009.08.019","article-title":"The yeast Candida albicans evades human complement attack by secretion of aspartic proteases.","volume":"47","author":"Gropp","year":"2009","journal-title":"Mol Immunol"},{"key":"R52-2-20210130","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1128\/IAI.00789-10","article-title":"The Inflammatory response induced by aspartic proteases of Candida albicans is independent of proteolytic activity.","volume":"78","author":"Pietrella","year":"2010","journal-title":"Infect Immun"},{"key":"R53-2-20210130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1128\/EC.00310-10","article-title":"Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis.","volume":"10","author":"Chen","year":"2011","journal-title":"Eukaryot Cell"},{"key":"R54-2-20210130","doi-asserted-by":"crossref","first-page":"e5039","DOI":"10.1371\/journal.pone.0005039","article-title":"A novel immune evasion strategy of Candida albicans: proteolytic cleavage of a salivary antimicrobial peptide.","volume":"4","author":"Meiller","year":"2009","journal-title":"PLoS One"},{"key":"R55-2-20210130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-4615-1941-6_41","article-title":"The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces.","volume":"371","author":"Brandtzaeg","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"R56-2-20210130","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1128\/IAI.67.6.2740-2745.1999","article-title":"Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands.","volume":"67","author":"Mathews","year":"1999","journal-title":"Infect Immun"},{"key":"R57-2-20210130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.chom.2010.08.002","article-title":"A biphasic innate immune MAPK response discriminates between the yeast and hyphal forms of Candida albicans in epithelial cells.","volume":"8","author":"Moyes","year":"2010","journal-title":"Cell Host Microbe"},{"key":"R58-2-20210130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrmicro2711","article-title":"Candida albicans morphogenesis and host defence: discriminating invasion from colonization.","volume":"10","author":"Gow","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"R59-2-20210130","doi-asserted-by":"crossref","first-page":"e1002379","DOI":"10.1371\/journal.ppat.1002379","article-title":"A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans.","volume":"7","author":"Tomalka","year":"2011","journal-title":"PLoS Pathog"},{"key":"R60-2-20210130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20081463","article-title":"Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis.","volume":"206","author":"Conti","year":"2009","journal-title":"J Exp Med"},{"key":"R61-2-20210130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1126\/scitranslmed.3000632","article-title":"Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.","volume":"2","author":"Favre","year":"2010","journal-title":"Sci Transl Med"},{"key":"R62-2-20210130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/mi.2010.22","article-title":"IL-22 defines a novel immune pathway of antifungal resistance.","volume":"3","author":"De Luca","year":"2010","journal-title":"Mucosal Immunol"},{"key":"R63-2-20210130","doi-asserted-by":"crossref","first-page":"e22770","DOI":"10.1371\/journal.pone.0022770","article-title":"Th17 cells and IL-17 in protective immunity to vaginal candidiasis.","volume":"6","author":"Pietrella","year":"2011","journal-title":"PLoS One"},{"key":"R64-2-20210130","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1182\/blood-2009-01-198028","article-title":"Vdelta1 T lymphocytes producing IFNg patients and IL-17 are expanded in HIV-infected and respond to Candida albicans.","volume":"113","author":"Fenoglio","year":"2009","journal-title":"Blood"},{"key":"R65-2-20210130","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.154.10.5273","article-title":"Growth inhibition of Candida albicans hyphae by CD8 lymphocytes.","volume":"154","author":"Beno","year":"1995","journal-title":"J Immunol"},{"key":"R66-2-20210130","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/IAI.63.1.280-288.1995","article-title":"Noninhibitory binding of human interleukin-2-activated natural killer cells to the germ tube forms of Candida albicans.","volume":"63","author":"Arancia","year":"1995","journal-title":"Infect Immun"},{"key":"R67-2-20210130","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/gut.2010.224774","article-title":"Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection.","volume":"60","author":"Haas","year":"2011","journal-title":"Gut"},{"key":"R68-2-20210130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1537","article-title":"Advances in combating fungal diseases: vaccines on the threshold.","volume":"5","author":"Cutler","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"R69-2-20210130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1473-3099(08)70016-1","article-title":"Fungal vaccines: real progress from real challenge.","volume":"8","author":"Cassone","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R70-2-20210130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0167-5699(93)90208-3","article-title":"A TH1TH2 switch is a critical step in the etiology of HIV infection.","volume":"14","author":"Clerici","year":"1993","journal-title":"Immunol Today"},{"key":"R71-2-20210130","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1016\/j.vaccine.2011.06.032","article-title":"Strong viremia control in vaccinated macaques does not prevent gradual Th17 cell loss from central memory.","volume":"29","author":"Demberg","year":"2011","journal-title":"Vaccine"},{"key":"R72-2-20210130","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1128\/JVI.02643-10","article-title":"CD4 T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors.","volume":"85","author":"Ciccone","year":"2011","journal-title":"J Virol"},{"key":"R73-2-20210130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clim.2011.02.008","article-title":"Long-term nonprogressors display a greater number of Th17 cells than HIV-infected typical progressors.","volume":"139","author":"Salgado","year":"2011","journal-title":"Clin Immunol"},{"key":"R74-2-20210130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"R75-2-20210130","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1189\/jlb.68.6.923","article-title":"Differential chemokine response of human monocytes to yeast and hyphal forms of Candida albicans and its relation to the beta-1,6 glucan of the fungal cell wall.","volume":"68","author":"Torosantucci","year":"2000","journal-title":"J Leukoc Biol"},{"key":"R76-2-20210130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2249.1997.2851176.x","article-title":"Responsiveness of human polymorphonuclear cells (PMNL) to stimulation by a mannoprotein fraction (MP-F2) of Candida albicans :enhanced production of IL-6 and tumor necrosis factor-alpha(TNF-alpha) by MP-F2-stimulated PMNL from HIV-infected subjects.","volume":"107","author":"Torosantucci","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"R77-2-20210130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/jlb.62.1.60","article-title":"Possible participation of polymorphonuclear cells stimulated by microbial immunomodulators in the dysregulated cytokine patterns of AIDS patients.","volume":"62","author":"Cassone","year":"1997","journal-title":"J Leukoc Biol"},{"key":"R79-2-20210130","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1046\/j.1523-1747.2002.01699.x","article-title":"Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence.","volume":"118","author":"Schaller","year":"2002","journal-title":"J Invest Dermatol"},{"key":"R80-2-20210130","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1128\/CDLI.00426-05","article-title":"Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.","volume":"13","author":"Kazmi","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"R81-2-20210130","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.4049\/jimmunol.154.7.3506","article-title":"Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons.","volume":"154","author":"Blauvelt","year":"1995","journal-title":"J Immunol"},{"key":"R83-2-20210130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2958.2008.06528.x","article-title":"Candida albicans cell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance.","volume":"71","author":"Frohner","year":"2009","journal-title":"Mol Microbiol"},{"key":"R84-2-20210130","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1074\/jbc.M110.130138","article-title":"The pH-regulated antigen 1 of Candida albicans binds the human complement inhibitor C4b-binding protein and mediates fungal complement evasion.","volume":"286","author":"Luo","year":"2011","journal-title":"J Biol Chem"},{"key":"R85-2-20210130","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/IAI.01282-10","article-title":"Recognition and blocking of innate immunity cells by Candida albicans chitin.","volume":"79","author":"Mora-Montes","year":"2011","journal-title":"Infect Immun"},{"key":"R86-2-20210130","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/yea.1790","article-title":"The Candida albicans cell wall protein Rhd3Pga29 is abundant in the yeast form and contributes to virulence.","volume":"27","author":"de Boer","year":"2010","journal-title":"Yeast"},{"key":"R87-2-20210130","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1128\/IAI.64.2.466-471.1996","article-title":"Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus.","volume":"64","author":"De Bernardis","year":"1996","journal-title":"Infect Immun"},{"key":"R88-2-20210130","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1099\/mic.0.049395-0","article-title":"Hyphal induction in the human fungal pathogen Candida albicans reveals a characteristic wall protein profile.","volume":"157","author":"Heilmann","year":"2011","journal-title":"Microbiology"},{"key":"R89-2-20210130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1099\/jmm.0.036269-0","article-title":"Increased expression of virulence attributes in oral Candida albicans isolates from human immunodeficiency virus-positive individuals.","volume":"61","author":"Mane","year":"2012","journal-title":"J Med Microbiol"},{"key":"R90-2-20210130","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/340035","article-title":"Evidence for differential expression of Candida albicans virulence genes during oral infection in intact and human immunodeficiency virus type 1-transgenic mice.","volume":"185","author":"Ripeau","year":"2002","journal-title":"J Infect Dis"},{"key":"R91-2-20210130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1128\/JCM.40.2.341-350.2002","article-title":"Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals.","volume":"40","author":"Vargas","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R92-2-20210130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2567.2001.01328.x","article-title":"Human immunodeficiency virus type 1 Tat binds to Candida albicans, inducing hyphae but augmenting phagocytosis in vitro.","volume":"104","author":"Gruber","year":"2001","journal-title":"Immunology"},{"key":"R93-2-20210130","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1086\/515231","article-title":"Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro.","volume":"177","author":"Gruber","year":"1998","journal-title":"J Infect Dis"},{"key":"R94-2-20210130","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/314871","article-title":"In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors.","volume":"180","author":"Cassone","year":"1999","journal-title":"J Infect Dis"},{"key":"R95-2-20210130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.femsim.2003.12.006","article-title":"Antiretroviral therapy with protease inhibitors decreases virulence enzyme expression in vivo by Candida albicans without selection of avirulent fungus strains or decreasing their antimycotic susceptibility.","volume":"41","author":"De Bernardis","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R97-2-20210130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00126334-199905010-00003","article-title":"Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study.","volume":"21","author":"Cauda","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R98-2-20210130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0162-3109(99)00035-1","article-title":"Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro.","volume":"41","author":"Gruber","year":"1999","journal-title":"Immunopharmacology"},{"key":"R99-2-20210130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1086\/426828","article-title":"Influence of indinavir on virulence and growth of Cryptococcus neoformans.","volume":"191","author":"Monari","year":"2005","journal-title":"J Infect Dis"},{"key":"R100-2-20210130","doi-asserted-by":"crossref","first-page":"e3382","DOI":"10.1371\/journal.pone.0003382","article-title":"Beneficial effects of HIV peptidase inhibitors on Fonsecaea pedrosoi: promising compounds to arrest key fungal biological processes and virulence.","volume":"3","author":"Palmeira","year":"2008","journal-title":"PLoS One"},{"key":"R101-2-20210130","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1086\/425584","article-title":"Antiretroviral as antimalarial agents.","volume":"190","author":"Skimer-Adams","year":"2004","journal-title":"J Infect Dis"},{"key":"R102-2-20210130","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2174\/092986711795843182","article-title":"Aspartic protease inhibitors as potential anti-Candida albicans drugs: impacts on fungal biology, virulence and pathogenesis.","volume":"18","author":"Braga-Silva","year":"2011","journal-title":"Curr Med Chem"},{"key":"R103-2-20210130","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1128\/JVI.02537-08","article-title":"A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN.","volume":"83","author":"Luallen","year":"2009","journal-title":"J Virol"},{"key":"R104-2-20210130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbrc.2006.04.059","article-title":"Biological activity of Tat (47-58) peptide on human pathogenic fungi.","volume":"345","author":"Jung","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"R105-2-20210130","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/JVI.01349-10","article-title":"Yeast-elicited cross-reactive antibodies to HIV Env glycans efficiently neutralize virions expressing exclusively high-mannose N-linked glycans.","volume":"85","author":"Agrawal-Gamse","year":"2011","journal-title":"J Virol"},{"key":"R106-2-20210130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10059-009-0136-6","article-title":"Candidacidal effects of Rev (11-20) derived from HIV-1 Rev protein.","volume":"28","author":"Lee","year":"2009","journal-title":"Mol Cells"},{"key":"R107-2-20210130","doi-asserted-by":"crossref","first-page":"e2371","DOI":"10.1371\/journal.pone.0002371","article-title":"Antibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities.","volume":"3","author":"Polonelli","year":"2008","journal-title":"PLoS One"},{"key":"R108-2-20210130","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/01.aids.0000222068.14878.0d","article-title":"A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.","volume":"20","author":"Casoli","year":"2006","journal-title":"AIDS"},{"key":"R109-2-20210130","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1128\/AAC.38.10.2495","article-title":"Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus.","volume":"38","author":"He","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"R110-2-20210130","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1086\/497373","article-title":"AIDS Clinical Trials Group Study Team 323; Mycoses Study Group Study Team 40. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323Mycoses Study Group Study 40.","volume":"41","author":"Goldman","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R111-2-20210130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0030-4220(94)90149-X","article-title":"Treatment of oral candidiasis in HIV infection.","volume":"78","author":"Grabar","year":"1994","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"R112-2-20210130","first-page":"2227","article-title":"Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.","volume":"12","author":"Hegener","year":"1998","journal-title":"AIDS"},{"key":"R113-2-20210130","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/AAC.01343-10","article-title":"Regulation of efflux pump expression and drug resistance by the transcription factors Mrr1, Upc2, and Cap1 in Candida albicans.","volume":"55","author":"Schubert","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R114-2-20210130","doi-asserted-by":"crossref","first-page":"e17589","DOI":"10.1371\/journal.pone.0017589","article-title":"Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata.","volume":"6","author":"Ferrari","year":"2011","journal-title":"PLoS One"},{"key":"R115-2-20210130","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"R116-2-20210130","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/423377","article-title":"A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.","volume":"39","author":"de Wet","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R117-2-20210130","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/423378","article-title":"A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis.","volume":"39","author":"Krause","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R118-2-20210130","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1086\/511039","article-title":"Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.","volume":"44","author":"Skiest","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R119-2-20210130","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1086\/323401","article-title":"A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis.","volume":"33","author":"Villanueva","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R120-2-20210130","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrd3074","article-title":"An insight into the antifungal pipeline: selected new molecules and beyond.","volume":"9","author":"Ostrowski-Zeichner","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"R121-2-20210130","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/jac\/dkl022","article-title":"Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis.","volume":"57","author":"Laverdiere","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R122-2-20210130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2174\/1389450023347542","article-title":"The secreted aspartic proteinases as a new target in the therapy of candidiasis.","volume":"3","author":"Bein","year":"2002","journal-title":"Curr Drug Targets"},{"key":"R123-2-20210130","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1021\/jm901734u","article-title":"Identification of inhibitors of drug-resistant Candida albicans strains from a library of bicyclic peptidomimetic compounds.","volume":"53","author":"Trabocchi","year":"2010","journal-title":"J Med Chem"},{"key":"R124-2-20210130","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/j.vaccine.2008.11.030","article-title":"Antibeta-glucan antibodies in healthy human subjects.","volume":"27","author":"Chiani","year":"2009","journal-title":"Vaccine"},{"key":"R125-2-20210130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1574-695X.2011.00802.x","article-title":"A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.","volume":"62","author":"Sandini","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R126-2-20210130","doi-asserted-by":"crossref","first-page":"e5392","DOI":"10.1371\/journal.pone.0005392","article-title":"Protection by antibeta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence.","volume":"4","author":"Torosantucci","year":"2009","journal-title":"PLoS One"},{"key":"R127-2-20210130","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20050749","article-title":"A novel glyco-conjugate vaccine against fungal pathogens.","volume":"202","author":"Torosantucci","year":"2005","journal-title":"J Exp Med"},{"key":"R128-2-20210130","doi-asserted-by":"crossref","first-page":"13526","DOI":"10.1073\/pnas.0803195105","article-title":"Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis.","volume":"105","author":"Xin","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R129-2-20210130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1086\/504691","article-title":"Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis.","volume":"194","author":"Spellberg","year":"2006","journal-title":"J Infect Dis"},{"key":"R130-2-20210130","doi-asserted-by":"crossref","first-page":"e1000703","DOI":"10.1371\/journal.ppat.1000703","article-title":"Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice.","volume":"5","author":"Lin","year":"2009","journal-title":"PLoS Pathog"},{"key":"R132-2-20210130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.2276","article-title":"Immune activation and inflammation in HIV-1 infection : causes and consequences.","volume":"214","author":"Appay","year":"2008","journal-title":"J Pathol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-201207310-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T13:17:24Z","timestamp":1713791844000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201207310-00002"}},"subtitle":["where commensalism, opportunistic behavior and frank pathogenicity lose their borders"],"short-title":[],"issued":{"date-parts":[[2012,7,31]]},"references-count":122,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3283536ba8","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,31]]}}}